Goodman & Company, Investment Counsel »

Apellis Pharmaceuticals shares owned by Goodman & Company, Investment Counsel

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Goodman & Company, Investment Counsel from 13F filings

Historical chart of Goodman & Company, Investment Counsel investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Goodman & Company, Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Goodman & Company, Investment Counsel

Quarter filed Position value Share count Share price at filing
2023-06-30 $60M 662k 91.10
2023-03-31 $8.6M 131k 65.96
2022-09-30 $6.0M 88k 68.30